Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00217165
Status:
COMPLETED
Last Update Posted:
2019-03-01
First Post:
2005-08-22
Brief Title:
Taurine as an Anti-Manic Agent A Double-Blind Placebo-Controlled Study
Sponsor:
Mclean Hospital
Organization:
Mclean Hospital
Study Overview
Official Title:
Taurine as an Anti-manic Agent a Double-blind Placebo-controlled Study
Status:
COMPLETED
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether the amino acid taurine has effects on mood stability in bipolar disorder
Detailed Description:
Taurine is an amino acid that has some actions similar to mood stabilizers Taurine is widely sold as a component of over-the-counter mood enhancing agents However controlled studies examining the mood effects of taurine are limited An initial study in this laboratory looked at taurines mood effects in individuals with bipolar disorder This follow-up study is designed to further examine taurines effects on manic symptoms Subjects in the current follow-up study will add taurine or placebo to their current treatment regimen Both depressive and manic symptoms will be tracked for three months to determine whether the addition of taurine affects mood symptoms
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None